InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Mahaney Paige. Director active across 1 company, notably C4 Therapeutics, Inc.. Cumulatively, 2 reports have been published. History available since 28 October 2024. The latest transaction was filed on 14 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations